{"id":"NCT00236080","sponsor":"Cephalon","briefTitle":"Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil (150, 200, and 250 mg) and PROVIGILÂ® (200 mg) in Patients With Chronic Shift Work Sleep Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":null,"completion":"2005-12","firstPosted":"2005-10-12","resultsPosted":"2010-02-03","lastUpdate":"2013-07-19"},"enrollment":136,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Shift Work Sleep Disorder"],"interventions":[{"type":"DRUG","name":"PROVIGIL 200 mg","otherNames":[]},{"type":"DRUG","name":"Armodafinil 250 mg","otherNames":[]},{"type":"DRUG","name":"Armodafinil 200 mg","otherNames":[]},{"type":"DRUG","name":"Armodafinil 150 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"EXPERIMENTAL"},{"label":"4","type":"EXPERIMENTAL"},{"label":"5","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to compare the overnight efficacy and plasma concentration-time profiles of armodafinil and PROVIGIL, after multiple doses, in patients with excessive sleepiness associated with chronic Shift Work Sleep Disorder (SWSD).","primaryOutcome":{"measure":"Multiple Sleep Latency Test (MSLT)","timeFrame":"Endpoint (Visit 4) change from baseline (Visit 2)","effectByArm":[{"arm":"PROVIGIL 200 mg/Day","deltaMin":2,"sd":3.05},{"arm":"Armodafinil 250 mg/Day","deltaMin":3.7,"sd":4.33},{"arm":"Armodafinil 200 mg/Day","deltaMin":3.7,"sd":5.07},{"arm":"Armodafinil 150 mg/Day","deltaMin":2.7,"sd":4.24},{"arm":"Placebo","deltaMin":1.1,"sd":3.76}],"pValues":[{"comp":"OG000 vs OG001 vs OG002 vs OG003 vs OG004","p":"0.1236"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":12},"locations":{"siteCount":20,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":["Headache","Decreased appetite","Dizziness","Nausea","Insomnia"]}}